Oxpro Pharma Private Limited, a active private limited company, was established on 04 June 2020 in Ranchi, Jharkhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909JH2020PTC014366. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Employing 80 professional, Its leadership includes Sarita Kumari (Additional Director), Sanjay Kumar (Managing Director), Saurabh Vidyarthi (Whole-Time Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at C/O Sanjay Kumar, F.N.-B2, 2Nd Floor, Wadhwani Tower, Karam Toli Chwok,, Ranchi, Jharkhand, 834008.
U51909JH2020PTC014366
014366
04 June 2020
₹1.00 Cr
₹1.00 Cr
Roc Ranchi
Unlisted
Active
Explore comprehensive insights into Oxpro Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarita Kumari | Additional Director | 02 Dec 2021 | Current |
| Sanjay Kumar | Managing Director | 04 Jun 2020 | Current |
| Saurabh Vidyarthi | Whole-Time Director | 04 Jun 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oxpro Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.67% increase. The company also saw a substantial improvement in profitability, with a 68.19% increase in profit. The company's net worth Soared by an impressive increase of 136.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Oxpro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Oxpro Pharma has a workforce of 80 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oxpro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxpro Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Oxpro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Oxpro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ranchi. was documented.
Sarita Kumari was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2021 & has been associated with this company since 4 years 21 days . was recorded as a recent event.
Progress on Sanjay Kumar was appointed as a Managing Director was appointed as a Managing Director on 04 Jun 2020 & has been associated with this company since 5 years 6 months . was documented.
Saurabh Vidyarthi was appointed as a Whole-time director was appointed as a Whole-time director on 04 Jun 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
The activity Oxpro Pharma Private Limited was registered on 04 Jun 2020 with Roc Ranchi & aged 5 years 6 months as per MCA records. was completed.
The CIN of Oxpro Pharma Private Limited is U51909JH2020PTC014366.
Oxpro Pharma Private Limited is headquartered at C/O Sanjay Kumar, F.N.-B2, 2Nd Floor, Wadhwani Tower, Karam Toli Chwok,, Ranchi, Jharkhand, 834008.
Oxpro Pharma Private Limited was incorporated on 04 June 2020.
The current directors of Oxpro Pharma Private Limited are
The primary industry of Oxpro Pharma Private Limited is Manufacturing.
Oxpro Pharma Private Limited is unlisted.
The authorized capital of Oxpro Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX